logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GSK
Stock Relay
25 Oct 14 21:21:41
$IMMY Last Price Click Here: http://t.co/2Wh1vWUnR5 Also See: $SCAI $MTL $GSK $SPRO ~
Jorge Ramírez
25 Oct 14 18:37:36
RT @pharmalot: Should drug makers be indemnified for their #ebola vaccines? What do you think? take our reader poll.. http://t.co/gEN7W7Ay3…
AIDSmeds
25 Oct 14 18:10:21
GlaxoSmithKline Eyes an IPO for HIV-Focused ViiV Healthcare $GSK @ViiVUS $PFE $TYO http://t.co/P2kKqi33Kt
John Gaeta
25 Oct 14 16:56:26
Looks like $GSK has the biggest lead in the race to cure #Ebola #biotech Won't hurt the company much if it isn't a success. Long $GSK
Chris Versace
25 Oct 14 16:42:36
Profit From the Longer Life Spans, Part 1 @TheStreet http://t.co/tl2wp5S9y3 $JNJ $NVS $PFE $MRK $BMY $GSK $AZN $HSIC $MCK $ZMH $XRAY #Aging
Stockaholics
25 Oct 14 13:49:14
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/dLDRavoCi4 $LFAP $GSK $ROX
John Schloegel
25 Oct 14 10:59:35
Every 90 days or so!! Heartattack at checkout. But that's why $GSK and $TEVA are moneyyyy!!! #hateashthma http://t.co/V6GOYN9Maa
Stockaholics
25 Oct 14 10:52:13
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/dLDRavoCi4 $LFAP $GSK $ROX
TalkMarkets
25 Oct 14 09:04:09
The 0.01% Global Investing $VALE $CZZ $ABGB $NOK $MSFT $AGU $GSK $FPRX $PT $FBASF http://t.co/C0eQPnjWgo
Fa$tlane $tocks
25 Oct 14 08:10:42
Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?" 10/23/2014 10:44 PM http://us.rd $GSK http://t.co/AZkCNrRBna
Get R Dun
25 Oct 14 08:02:46
RT @StockSignaling: Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $N…
The Double Dip
25 Oct 14 08:02:34
RT @StockSignaling: Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $N…
Stock Signaling
25 Oct 14 08:02:18
Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $NLNK #dow #nyse #mkt
Yudha Saputra
25 Oct 14 07:45:31
RT @pharmalot: ICYMI: Should drug makers be indemnified for #Ebola vaccines? what do u think? take our reader poll http://t.co/gEN7W7Ay31 #…
Stefanie Ilgenfritz
25 Oct 14 07:44:24
RT @pharmalot: ICYMI: Should drug makers be indemnified for #Ebola vaccines? what do u think? take our reader poll http://t.co/gEN7W7Ay31 #…
Michael Bryant
25 Oct 14 07:24:12
"WHO eyes mass Ebola vaccines by mid-2015." Hope for ChAd3, made by GlaxoSmithKline ($GSK). Maybe buy $GSK??? http://t.co/4hprCLmtj7
Marilyn Mann
25 Oct 14 07:13:22
RT @pharmalot: ICYMI: Should drug makers be indemnified for #Ebola vaccines? what do u think? take our reader poll http://t.co/gEN7W7Ay31 #…
ChrisMLindgren
25 Oct 14 07:12:20
RT @pharmalot: ICYMI: Should drug makers be indemnified for #Ebola vaccines? what do u think? take our reader poll http://t.co/gEN7W7Ay31 #…
pharmalot
25 Oct 14 07:11:01
ICYMI: Should drug makers be indemnified for #Ebola vaccines? what do u think? take our reader poll http://t.co/gEN7W7Ay31 #pharma $GSK
AlsoThere
25 Oct 14 00:26:47
RT @StockSignaling: Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $N…
Stockaholics
25 Oct 14 00:21:58
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/Wsu24zYrur $LFAP $GSK $ROX
Patrick
25 Oct 14 00:07:25
RT @StockSignaling: Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $N…
Bon Bright
24 Oct 14 23:16:55
$GSK http://t.co/rBvUfxVref
Todd Moody
24 Oct 14 22:27:37
RT @PipsToDollars: Here are all the ebolas bios @TamaraTattles $CMRX $TKMR $INO $SRPT $BCRX $NLNK $NPSP LABS $GSK $EBS $NVS
中津川亮
24 Oct 14 21:52:30
RT @FiercePharma: Sanofi to roll out quadrivalent flu jab in Canada amid $GSK manufacturing woes http://t.co/J9Mc48oAQs $SNY #pharma #vacci…
Karen Keeley
24 Oct 14 21:41:49
RT @PipsToDollars: Here are all the ebolas bios @TamaraTattles $CMRX $TKMR $INO $SRPT $BCRX $NLNK $NPSP LABS $GSK $EBS $NVS
Timothy Poore
24 Oct 14 20:45:47
RT @ScripDonnaDC: Stakeholders agree to start Ebola vaccine efficacy trials December http://t.co/qNnlwVj8XT #Ebola #NIH #CDC #WHO $GSK $NL…
SCRIP Intelligence
24 Oct 14 20:40:58
RT @ScripDonnaDC: Stakeholders agree to start Ebola vaccine efficacy trials December http://t.co/qNnlwVj8XT #Ebola #NIH #CDC #WHO $GSK $NL…
US Banking News
24 Oct 14 20:28:45
GlaxoSmithKline plc Rating Reiterated by Liberum Capital $GSK http://t.co/muJx8smivb
Leilani Pips
24 Oct 14 20:13:22
Here are all the ebolas bios @TamaraTattles $CMRX $TKMR $INO $SRPT $BCRX $NLNK $NPSP LABS $GSK $EBS $NVS
Avon
24 Oct 14 17:33:17
RT @StockSignaling: Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $N…
Stock Signaling
24 Oct 14 17:32:34
Movers and Shakers: Recently Upgraded: $DCT $NCR $GIMO $SWFT $MXIM $NUE $POT $YNDX $STNG $TSCO $INFN $GSK $YELP $DOW $NLNK #finance #spy
Clyde Eltzroth
24 Oct 14 17:07:45
RT @ScripDonnaDC: Stakeholders agree to start Ebola vaccine efficacy trials December http://t.co/qNnlwVj8XT #Ebola #NIH #CDC #WHO $GSK $NL…
Donna Young
24 Oct 14 16:59:49
Stakeholders agree to start Ebola vaccine efficacy trials December http://t.co/qNnlwVj8XT #Ebola #NIH #CDC #WHO $GSK $NLNK $JNJ #pharma
BioProcessOnline
24 Oct 14 16:55:55
RT @FierceBiotech: $GSK cozies up to Five Prime for respiratory R&D - http://t.co/dAuL1C8otz by @DamianFierce
ʇɐpıʍdnznʍ
24 Oct 14 16:24:39
@BadBoyzAuction Nope.... Don't know much about it. Only know of $TKMR & $GSK.
ʇɐpıʍdnznʍ
24 Oct 14 16:23:14
@BadBoyzAuction I've been watching it but never acted. The $GSK calls look much more appealing.
A P
24 Oct 14 15:37:32
$GSK Director/PDMR Shareholding http://t.co/AObt42MSXJ #BiotechTraderHandbook--> http://t.co/JDdc1OTfZF
Stockaholics
24 Oct 14 14:58:54
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/Wsu24zYrur $LFAP $GSK $ROX
HarborPath
24 Oct 14 14:35:19
RT @pozmagazine: GlaxoSmithKline Eyes an IPO for HIV-Focused ViiV Healthcare $GSK @ViiVUS $PFE $TYO http://t.co/mLQQtPw0SY
US Banking News
24 Oct 14 14:20:00
GlaxoSmithKline plc’s “Sell” Rating Reiterated at Liberum Capital $GSK http://t.co/2t3btC2xHj
For_the_Roses
24 Oct 14 14:03:43
RT @fwpharma: ViewPoints: GlaxoSmithKline sees calmer skies ahead, but was it braced for pricing storm? http://t.co/u1Dcf8NiTh $GSK #pharma
The GMP Group
24 Oct 14 14:02:30
RT @fwpharma: ViewPoints: GlaxoSmithKline sees calmer skies ahead, but was it braced for pricing storm? http://t.co/u1Dcf8NiTh $GSK #pharma
FirstWord Pharma
24 Oct 14 14:00:31
ViewPoints: GlaxoSmithKline sees calmer skies ahead, but was it braced for pricing storm? http://t.co/u1Dcf8NiTh $GSK #pharma
NiCO
24 Oct 14 13:50:37
@nick0demus and same in Sierra Leone but without placebo vaccines $NLNK $GSK
NiCO
24 Oct 14 13:48:36
@nick0demus apparently due to terminal news re 3000 $NLNK, 3000 $GSK & 3000 placebo vaccines starting trial in Liberia
Leilani Pips
24 Oct 14 13:26:44
EARNINGS CALL-9/11 $YHOO C $AAPL C $CMG P $ANGI P $GSK P $MCD P $AMZN P $SWFT C $F P WRONG $NFLX $YELP
Analyst Ratings
24 Oct 14 13:20:05
GlaxoSmithKline plc (ADR)'s sell rating reiterated at Liberum Capital. http://t.co/q7D5HWayVM $GSK #GSK
US Consumer News
24 Oct 14 13:19:27
GlaxoSmithKline plc (ADR)'s sell rating reiterated at Liberum Capital. http://t.co/7vGSh8pHCd $GSK #GSK
Patricia Carter
24 Oct 14 13:05:45
RT @ScripDonnaDC: #NIH #NIAID Fauci: Incentive for industry was not previously there for #Ebola vaccine; cards all come together now $GSK $…
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.